POINT Biopharma Global Total Assets

POINT Biopharma Global (PNT) currently reports a total assets of $480M as of September 2023. That compares with $330M in the prior-year period — up 46.7% year over year. Use the charts on this page to explore POINT Biopharma Global's total assets history and peer comparisons.

POINT Biopharma Global's total assets increased from $330M to $480M — a 46.7% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

POINT Biopharma Global reported $480M in total assets as of September 2023. That compares with $330M in the prior-year period — up 46.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $480M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for POINT Biopharma Global, and consider following PNT for alerts when major investors trade the stock.

POINT Biopharma Global is classified in the Healthcare sector. On total assets, it currently shows $480M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PNT with unrelated industries.